Results 111 to 120 of about 1,366 (170)

Nanoformulations of essential oils for the treatment of fungal diseases, with a focus on dermatophytes. [PDF]

open access: yesArch Microbiol
Chattha GM   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Immunoresponses in dermatomycoses

Journal of Dermatology, 2015
AbstractContact with fungal pathogens initiates a series of host responses beginning with innate immunity, which leads to fungal recognition and microbial killing. The innate immune system also modulates the adaptive immune responses, leading to the establishment of immunological memory and protection against pathogens.
Yayoi Tada, Shinichi Watanabe
exaly   +3 more sources

Dermatomycoses

Nederlands tijdschrift voor tandheelkunde, 2011
Errol Reiss   +2 more
exaly   +4 more sources

Dermatomycoses in Indonesia

International Journal of Dermatology, 1984
ABSTRACT: A review of mycologic surveys and case reports indicates the unique occurrence of deep and superficial fungus infections of the skin as encountered in Indonesia, confirming that each country has its own pathogenic mycologic flora. Such diseases as phycomycosis, histoplasmosis, mycetoma, chromomycosis, cryptococcosis, and dermatophytosis are ...
M, Harahap, M A, Nasution
openaire   +2 more sources

Study of Dermatomycoses

International Journal of Dermatology, 1981
ABSTRACT: 555 clinically suspected cases of dermatomycoses were studied for causative fungi and their detailed clinical manifestations. The fungi were demonstrated on routine KOH mount and/or by culture in 464 cases (83.6%). Tinea corporis was the predominant fungal infection (30.6%) and T. rubrum was the main etiologic agent. Favus (T.
R K, Khosa   +4 more
openaire   +2 more sources

GRISEOFULVIN IN DERMATOMYCOSES

JAMA, 1960
Griseofulvin was administered orally in uniform doses of 1,000 mg. daily to 80 patients with dermatomycoses due to Trichophyton mentagrophytes, Trichophyton rubrum, Candida albicans, Epidermophyton floccosum, and Microsporum lanosum. Studies of blood and urine were made at four-week intervals.
G C, ANDREWS, A N, DOMONKOS, A, SILVA
openaire   +2 more sources

Immunotherapy of Superficial Dermatomycoses

Dermatologica, 2009
The long-range efficacy of the standard treatment for superficial dermatomycoses is, in the majority of cases, unsatisfactory, even despite the advent of griseofulvin. The present paper reports an attempt to treat patients suffering from superficial dermatomycoses (Monilia and tinea) by specific immunotherapy. The follow-up period on patients receiving
A, Tager   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy